These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6361152)

  • 21. Production of monospecific antibodies to varicella zoster virus antigen in rabbits tolerant to human IgG and immunized with antigen immunoprecipitated with human IgG from zoster reconvalescent sera.
    Hansen BL; Vestergaard BF; Hansen GN
    J Immunol Methods; 1981; 43(3):283-90. PubMed ID: 6265561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of potent Salmonella H antisera by immunization with polymeric flagellins.
    Ibrahim GF; Fleet GH; Lyons MJ; Walker RA
    J Clin Microbiol; 1985 Sep; 22(3):347-51. PubMed ID: 2413067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple method for the production of specific antiserum to protein encoded in cloned genes. Immunization with precipitin lines.
    Shapiro SZ; Kimmel BE
    J Immunol Methods; 1987 Mar; 97(2):275-9. PubMed ID: 3102616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel antibody overlay technique for two-dimensional immunoelectrophoresis.
    Lebecq JC; Salhi SL; Bastide JM
    J Immunol Methods; 1984 Feb; 66(2):219-26. PubMed ID: 6361150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice].
    Bulava GV; Ermolin GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific antisera produced by direct immunization with slices of polyacrylamide gel containing small amounts of protein.
    Boulard C; Lecroisey A
    J Immunol Methods; 1982; 50(2):221-6. PubMed ID: 6282975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation in relation to protective function of antibodies to Escherichia coli O antigens.
    Ahlstedt S; Hanson LA
    Scand J Immunol; 1975 Sep; 4(5-6):511-5. PubMed ID: 1101368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective capacity of antibodies against Escherichia coli and K antigens.
    Kaijser B; Ahlstedt S
    Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific antisera produced by immunization with precipitin lines.
    Kroll J; Andersen MM
    J Immunol Methods; 1976; 13(2):125-30. PubMed ID: 977958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
    Ahlstedt S; Kaijser B
    Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monospecific serum for typing Haemophilus influenzae type b produced by immunization with Escherichia coli strain 'Easter'.
    Aaron L; Handzel Z; Argaman M; Schneerson R; Robbins JB
    J Biol Stand; 1974 Jan; 2(1):25-31. PubMed ID: 4213257
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of murine C-type virus structural proteins by rocket and crossed immunoelectrophoresis.
    Georgiades JA; Billiau A; Verbruggen R; de Somer P
    J Immunol Methods; 1977; 17(1-2):177-87. PubMed ID: 198476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an immunological relationship between Streptococcus mutans and human cardiac tissue.
    Hughes M; Machardy SM; Sheppard AJ; Woods NC
    Infect Immun; 1980 Feb; 27(2):576-88. PubMed ID: 6991419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agglutinating efficiency and combining capacity of Shigella and Vibrio antisera from rabbits at different stages of immunization.
    FRETER R
    J Exp Med; 1957 Jun; 105(6):623-34. PubMed ID: 13428929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization procedures for E. coli proteins.
    Anicetti VR; Simonetti MA; Blackwood LL; Jones AJ; Chen AB
    Appl Biochem Biotechnol; 1989 Nov; 22(2):151-68. PubMed ID: 2692518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of CFA/I expression by enteropathogenic E. coli following exposure to antibody.
    Dean GS; Wansbrough-Jones MH
    Clin Exp Immunol; 1983 May; 52(2):293-6. PubMed ID: 6345037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyclonal antibodies to rabbit skeletal muscle protein phosphatases C-I and C-II.
    Wei Q; Pervaiz S; Lee EY
    Arch Biochem Biophys; 1989 Jul; 272(1):69-75. PubMed ID: 2544144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental substantiation of the possibility to obtain anti-Proteus plasma].
    Nazarchuk LV; Zverkova AS; Koval' AI; Kubrachenko SIa; Fedorovs'ka OO
    Fiziol Zh (1978); 1992; 38(3):40-3. PubMed ID: 1499760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isolation of monospecific antisera to guinea pig immunoglobulins].
    Guzova VA; Batalova TN; Vorob'ev AA; Afanas'ev SS; Savvé VD
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):81-5. PubMed ID: 2741609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.